Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. (Q51369477)
Jump to navigation
Jump to search
scientific article published on 12 April 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. |
scientific article published on 12 April 2016 |
Statements
1 reference
Sustained inhibition of cMET-VEGFR2 signaling using liposome-mediated delivery increases efficacy and reduces toxicity in kidney cancer. (English)
1 reference
1 reference
Vijay Elakkya Vijaykumar
1 reference
Shiladitya Sengupta
1 reference
Venkata S Sabbisetti
1 reference
12 April 2016
1 reference
12
1 reference
7
1 reference
1853-1861
1 reference
Identifiers
1 reference